- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0244426

Effimed Research Private Limited
About Effimed Research Private Limited
Data last updated:
Effimed Research Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the research and development sector. It was incorporated on 29 March 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85100KA2010PTC053032. Its GSTIN is 29AACCE3805E1ZX (Karnataka).
The company has an authorised share capital of ₹8 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Hans Thilo Bayrhoffer and Madhusudhan Chakrabavi Sreenivasa Murthy.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 87 1st Main Micolayout Btm 2nd Stage., Bangalore, Karnataka, India – 560076.
As per the financials filed for FY 2025, the company reported a revenue of ₹60,000. For the same year it recorded a net profit of ₹25,140 (net margin 41.9%) and EBITDA of ₹29,800 (EBITDA margin 49.7%). Revenue has grown at a compounded annual rate (CAGR) of 198% over five years.
Effimed Research Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0244426). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Effimed Research
Contact details
Effimed Research Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo 87 1st Main Micolayout Btm 2nd Stage., Bangalore, Karnataka, India – 560076
- IndustryResearch & Development, Research & Development
To see the full contact details of Effimed Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Effimed Research Private Limited
FY 2025 filings availableEffimed Research Private Limited reported revenue of ₹60,000 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 198% over five years. EBITDA rose 107% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29,800 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25,140 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 49.7% | ||||
| Net Profit Margin | 41.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Effimed Research Private Limited, buy the company report.
Board of directors of Effimed Research Private Limited
Effimed Research has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hans Thilo Bayrhoffer | Director | 28 Feb 2011 | 15 Years 8 Months | Current |
| Madhusudhan Chakrabavi Sreenivasa Murthy | Director | 01 Apr 2010 | 16 Years 6 Months | Current |
Shareholding
The shareholding of Effimed Research Private Limited is on record for FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Effimed Research Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Effimed Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Effimed Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Effimed Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCE3805E1ZX | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Effimed Research Private Limited, buy the company report.
Recent activity
Effimed Research Private Limited has 6 board changes on record since 2010: 2 appointments and 4 cessations. The latest: Joern Nikolaus Leewe ceased to be Director on 12 Apr 2013.
Frequently asked questions
Effimed Research is an active private limited company based in Bangalore, Karnataka, India. The company works in the research and development industry. It was incorporated on 29 March 2010 (16+ years old) and is registered under CIN U85100KA2010PTC053032.
Effimed Research has 2 current directors:
- Hans Thilo Bayrhoffer - Director
- Madhusudhan Chakrabavi Sreenivasa Murthy - Director
The latest financial statements of Effimed Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Effimed Research is 29AACCE3805E1ZX, registered in Karnataka.
The CIN (Corporate Identification Number) of Effimed Research is U85100KA2010PTC053032. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Effimed Research was incorporated on 29 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Bangalore.
Joern Nikolaus Leewe ceased to be Director on 12 Apr 2013. Madhusudhan Chakrabavi Sreenivasa Murthy ceased to be Additional Director on 29 Sep 2011. Guru Prasad Makam ceased to be Director on 08 Mar 2011. Effimed Research has 6 board changes on record in total.
Yes, Effimed Research is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0244426).
The registered office of Effimed Research is at No 87 1st Main Micolayout Btm 2nd Stage., Bangalore, Karnataka, India – 560076.
Effimed Research operates in the research and development industry.